You are here: / products
Incontinence
Erectile Dysfunction (ED)
Impotence is a consistent inability to maintain and sustain an erection sufficient for sexual intercourse. The analogy of achieving an erection is frequently used to filling a tire with air. Achieving an erection takes air forced under pressure. More importantly, it takes an intact "tire" without a hole to maintain the air and allow it to expand. A defect in either of these two aspects will cause a "flat tire”.read more
Female Sexual Dysfuction (FSD)
The Eros TherapyTM is a small, handheld medical device that improves sexual responses by increasing blood flow to the clitoris and external genitalia. A small, soft plastic cup is placed over the clitoris. When the Eros is turned on, a gentle vacuum is created, increasing blood flow to the genitalia causing the clitoris to become engorged. Increased blood flow to the genitalia results in increased vaginal lubrication and enhanced ability to achieve orgasm. The Eros TherapyTM received FDA clearance-to-market in April 2000.read more
products
IncontinenceErectile Dysfunction (ED) Impotence is a consistent inability to maintain and sustain an erection sufficient for sexual intercourse. The analogy of achieving an erection is frequently used to filling a tire with air. Achieving an erection takes air forced under pressure. More importantly, it takes an intact "tire" without a hole to maintain the air and allow it to expand. A defect in either of these two aspects will cause a "flat tire”.
read moreFemale Sexual Dysfuction (FSD)The Eros TherapyTM is a small, handheld medical device that improves sexual responses by increasing blood flow to the clitoris and external genitalia. A small, soft plastic cup is placed over the clitoris. When the Eros is turned on, a gentle vacuum is created, increasing blood flow to the genitalia causing the clitoris to become engorged. Increased blood flow to the genitalia results in increased vaginal lubrication and enhanced ability to achieve orgasm. The Eros TherapyTM received FDA clearance-to-market in April 2000.
read more
